STABILITY STUDY OF AMLODIPINE BESYLATE AND BISOPROLOL FUMARATE IN AQUEOUS SOLUTIONS
DOI:
https://doi.org/10.7251/COMEN1402212VAbstract
Valuable information concerning stability of compounds can be obtained by using different media (water, hydrochloric acid or sodium hydroxide) for dissolution of active pharmaceutical substances. Furthermore, additional knowledge is gained by performing experiments at different temperatures. This research paper deals with the stability of amlodipine besylate and bisoprolol fumarate in different media at different temperatures, whereby certain conclusions are drawn. For stability assessment, chemical kinetics approach was used, and constant rate (k), half-time (t1/2) and activation energy (Ea) were used for prediction of compound stability degree. The stability of amlodipine besylate and bisoprolol fumarate were tested, both separately and in mixture, in water and in 0.01M HCl. All the investigated solutions were treated at two temperatures 25° and 70°C at the following time intervals: 0, 1 h, 24 h, 48 h and 72 h. Hydrophilic Interaction Liquid Chromatography – HILIC method, previously developed and validated, was used. On the basis of obtained results it was concluded that amlodipine-besylate was more stable in water than in acid medium, more stable in mixture rather than individually and more stable at lower temperatures.
This was confirmed by the obtained values of monitored parameters: amlodipine besylate Ea = 30.68 kJ mol-1, k (25 °C) = 0.000333 mM h-1, k (70 °C) = 0.00169 mM h-1; amlodipine besylate in mixture Ea = 42,414 kJ mol-1, k (25 °C) = 1.27∙10-4 mM h-1,
k (70 °C) = 0.0012 mM h-1. Based on the obtained approximate Ea value for bisoprolol fumarate in acid (59 kJ mol-1) and in water (56 kJ mol-1), bisoprolol fumarate showed excellent stability against the media in which it was studied. On the other hand, the temperature had a significant effect on the stability of bisoprolol fumarate. These results provide the relevant information about the stability of the tested active substances, and may be of importance during the development of an appropriate pharmaceutical product. A bigger influence on the stability of bisoprolol fumarate had a temperature effect.
References
[2] G. Vuleta, J. Milić, M. Primorac, S. Savić, Pharmaceutical Technology I [In Serbian: Farmaceutska tehnologija], Belgrade University, Faculty of Pharmacyt, Belgrade 2012.
[3] European Pharmacopoeia, 7th Edition, Council of Europe, Strasbourg 2011.
[4] B. Tubić, I. Kasagić Vujanović, N. Mihajlica, Ž. Gagić, N. Bubić Pajić, Testing the contents of active substance and degradation products/impurities in nimesulide tablets by application of reverse-phase fluid chromatography under a high pressure [In Serbian: Ispitivanje sadržaja aktivne supstance i degradacionih proizvoda/nečistoća u tabletama nimesulida primjenom reverzno-fazne tečne hromatografije pod visokim pritiskom], Arh farm, Vol. 63 (2013) 1–19.
[5] Guideline on stability testing, EMA [Internet]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003466.pdf (Accessed: 03. 09. 2014.)
[6] M. Medenica, D. Malešev, Experimental Physical Chemistry [In Serbian: Eksperimentalna fizička hemija], Beograd 2002.
[7] S. Yoshioka,V. J. Stella, Stability of Drugs and Dosage Forms, Springer Science&Business Media, Vol 12–31 (2000) 268.
[8] S. Bajaj, D. Singla, N. Sakhuja, Stability Testing of Pharmaceutical Products, Journal of Applied Pharmaceutical Science, Vol. 2 (2012) 129–138.
[9] M. E. Aulton, Pharmaceutics the science of dosage form design, Churchill Livingston, 2001.
[10] T. C. Jens, Pharmaceutics of solids and solid dosage forms, Journal of Pharmaceutical Sci-ences, New York 1977.
[11] D. N. Vora, A. A. Kadav, Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets, Indian J Pharm Sci, Vol. 70 (2008) 542–546.
[12] P. Shalini, P. Krishan, Development and Validation of a Simultaneous HPLC Method for Assay and Dissolution of Bisoprolol fumarate and Amlodipine besylate in Pharmaceutical Dosage. RJPDFT, Vol. 4 (2012) 62–66.
[13] A. J. Braza, P. Modamio, C. F. Lastra, E. L. Mariño, Development, validation and analytical error function of two chromatographic methods with fluorometric detection for the determination of bisoprolol and metoprolol in human plasma, Biomed Chromatogr, Vol. 16 (2002) 517–522.
[14] S. T. Ulu, Z. Aydoğmuş, An HPLC Method for the Determination of Bisoprolol in Human Plasma and its Application to a Pharmacokinetic Study, J Chromatogr Sci, Vol. 50 (2012) 615–619.
[15] B. Bozal, M. Gumustas, B. Dogan–Topal, B. Uslu, S. A. Ozkan, Fully validated simultaneous determination of bisoprolol fumarate and hydrochlorothiazide in their dosage forms using different voltammetric, chromatographic, and spectrophotometric analytical methods, J AOAC Int, Vol. 96 (2013) 42–51.
[16] K. H. Gopani, S. S. Havele, S. R. Dhaneshwar, Application of high performance thin layer chromatography densitometry for the simultaneous determination of amlodipine besylate and lisi-nopril in bulk drug and tablet formulation, IJPT, Vol. 3 (2011) 2353–2367.
[17] S. B. Wankhede, K. C. Raka, S. Wadkar, S. S. Chitlange, Spectrophotometric and HPLC Methods for Simultaneous Estimation of Amlodipine Besilate, Losartan Potassium and Hydrochlorothiazide in Tablets, Indian J Pharm Sci, Vol. 72 (2010) 136–140.
[18] V. Vichare, V. Tambe, V. Kashikar, S. N. Dhole, Spectrophotometric simultaneous determination of amlodipine and hydrochlorthiazide in combined tablet dosage form by simultaneous equation, absorption ratio and first order derivate spectroscopy methods, Int J Chem Res, Vol. 2 (2011) 7–10.
[19] S. P. Pournima, N. M. Harinath, A. P. Ishwikar, RP–HPLC method for simultaneous esti-mation of amlodipine besylate and olmesartan medoxomil from tablet, Int J Pharm Pharm Sci, Vol. 3 (2011) 146–149.
[20] C. H. M. M. Prasada Rao, S. A. Rahaman, Y. R. Prasad, P. G. Reddy, RP–HPLC method of simultaneous estimation of amlodipine besylate and metoprolol in combined dosage form, IJPRD, Vol. 9 (2010) 69–76.
[21] J. Zhao, H. L. Wu, J. F. Niu, Y. J. Yu, L. L. Yu, C. Kang, Q. Li, X. H. Zhang, R. Q. Yu, Chemometric resolution of coeluting peaks of eleven antihypertensives from multiple classes in high performance liquid chromatography: A comprehensive research in human serum, health product and Chinese patent medicine samples, J Chromatogr, Vol. 902 (2012) 96–107.
[22] L. Kristoffersen, E. L. Øiestad, M. S. Opdal, M. Krogh, E. Lundanes, A. S. Christophersen, Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhythmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry. Method development and robustness testing by experimental design, J Chromatogr B Analyt Technol Biomed Life Sci, Vol. 850 (2007) 147–160.
[23] N. L. Padivitage, D. W. Armstrong, Sulfonated cyclofructan 6 based stationary phase for hydrophilic interaction chromatography, J Sep Sci, Vol. 34 (2011) 1636–1647.
[24] A. L. Van Nuijs, I. Tarcomnicu, W. Simons, L. Bervoets, R. Blust, P. G. Jorens, H. Neels, A. Covaci, Optimization and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater, Anal Bioanal Chem, Vol. 398 (2010) 2211–2222.
[25] D. W. Jeong, H. Y. Kim, H. Y. Ji, Y. S. Youn, K. C. Lee, H. S. Lee, Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry, J Pharm Biomed Anal, Vol. 44 (2007) 547–552.
[26] N. S. Quiming, N. L. Denola, I. Ueta, Y. Saito, S. Tatematsu, K. Jinno, Retention prediction of adrenoreceptor agonists and antagonists on a diol column in hydrophilic interaction chromatography, Anal Chim Acta, Vol. 598 (2007) 41–50.
